Siga Technologies (FRA:SGW) Inventories, Finished Goods : €3.9 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Siga Technologies Inventories, Finished Goods?

Siga Technologies's quarterly finished goods declined from Sep. 2023 (€9.3 Mil) to Dec. 2023 (€2.3 Mil) but then increased from Dec. 2023 (€2.3 Mil) to Mar. 2024 (€3.9 Mil).

Siga Technologies's annual finished goods increased from Dec. 2021 (€1.8 Mil) to Dec. 2022 (€5.5 Mil) but then declined from Dec. 2022 (€5.5 Mil) to Dec. 2023 (€2.3 Mil).

Siga Technologies Inventories, Finished Goods Historical Data

The historical data trend for Siga Technologies's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siga Technologies Inventories, Finished Goods Chart

Siga Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.86

1.83

1.80

5.54

2.30

Siga Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															5.66	8.32	9.28	2.30	3.90

Siga Technologies Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Siga Technologies (FRA:SGW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siga Technologies Inc (FRA:SGW) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

SIGA:USA

Address

31 East 62nd Street, New York, NY, USA, 10065

Website

http://www.siga.com

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus.

Siga Technologies (FRA:SGW) Headlines

No Headlines